Bone Loss Recruiting Phase 4 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs